Expansion of lead KIF18Ai program in lung, head and neck cancers following early positive resultsGenetic biomarker signatures show early correlation with KIF18Ai clinical responseCompany reports ...
Sagimet Biosciences Inc. remains a Strong Buy, driven by positive PK Denifanstat + Resmetirom combination data and advancing clinical programs in acne and MASH. SGMT's denifanstat plus resmetirom ...
Opna Bio, a clinical-stage biopharmaceutical company focused on the discovery and development of novel oncology therapeutics, announced today that it will have an oral and a poster presentation at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback